Fluvoxamine approved for treating OCD in children.
D000293:Adolescent; D000367:Age Factors; D014151:Anti-Anxiety Agents / Q000627:therapeutic use*; D002648:Child; D017277:Drug Approval; D016666:Fluvoxamine / Q000627:therapeutic use*; D006801:Humans; D009771:Obsessive-Compulsive Disorder / Q000188:drug therapy*; D018579:Patient Selection; D017367:Selective Serotonin Reuptake Inhibitors / Q000627:therapeutic use*; D014481:United States; D014486:United States Food and Drug Administration
D014151:Anti-Anxiety Agents; D016666:Fluvoxamine; D017367:Selective Serotonin Reuptake Inhibitors